IBDEI3A2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52310,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,52311,0)
 ;;=I13.10^^193^2528^10
 ;;^UTILITY(U,$J,358.3,52311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52311,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,52311,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,52311,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,52312,0)
 ;;=I13.11^^193^2528^11
 ;;^UTILITY(U,$J,358.3,52312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52312,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,52312,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,52312,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,52313,0)
 ;;=I13.2^^193^2528^9
 ;;^UTILITY(U,$J,358.3,52313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52313,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,52313,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,52313,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,52314,0)
 ;;=I15.0^^193^2528^15
 ;;^UTILITY(U,$J,358.3,52314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52314,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,52314,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,52314,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,52315,0)
 ;;=I15.1^^193^2528^3
 ;;^UTILITY(U,$J,358.3,52315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52315,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,52315,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,52315,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,52316,0)
 ;;=I15.2^^193^2528^2
 ;;^UTILITY(U,$J,358.3,52316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52316,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,52316,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,52316,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,52317,0)
 ;;=I15.8^^193^2528^16
 ;;^UTILITY(U,$J,358.3,52317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52317,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,52317,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,52317,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,52318,0)
 ;;=I15.9^^193^2528^17
 ;;^UTILITY(U,$J,358.3,52318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52318,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,52318,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,52318,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,52319,0)
 ;;=I16.0^^193^2528^14
 ;;^UTILITY(U,$J,358.3,52319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52319,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,52319,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,52319,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,52320,0)
 ;;=I16.1^^193^2528^7
 ;;^UTILITY(U,$J,358.3,52320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52320,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,52320,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,52320,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,52321,0)
 ;;=I16.9^^193^2528^6
 ;;^UTILITY(U,$J,358.3,52321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52321,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,52321,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,52321,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,52322,0)
 ;;=A07.0^^193^2529^5
 ;;^UTILITY(U,$J,358.3,52322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52322,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,52322,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,52322,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,52323,0)
 ;;=A07.1^^193^2529^9
